AstraZeneca seeks European OK for aspirin product

[June 04, 2010]  LONDON (AP) -- AstraZeneca says it has applied for authorization to market in Europe a drug combining low-dose aspirin with its best-selling ulcer drug Nexium.

The pharmaceutical company said Friday that the product, called Axanum, is designed for heart patients who develop gastric disorders from taking low-dose aspirin by itself.

On Tuesday, AstraZeneca said the U.S. Food and Drug Administration has asked for more information about Axanum, delaying the company's hopes of selling the product in America.

[Associated Press]

Copyright 2010 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.